North America Extracorporeal CO2 Removal Devices Market Size, Share & Industry Trends Analysis Report By Application, By End-Use, By Product, By Access, By Country and Growth Forecast, 2023

List of Tables

The North America Extracorporeal CO2 Removal Devices Market would witness market growth of 6.1% CAGR during the forecast period (2023-2030).

ECCO2R may be employed as a bridge to lung transplantation for patients awaiting lung donor matching. It helps maintain acceptable blood gas levels while waiting for a suitable donor organ. These Devices can be used during severe COPD exacerbations when conventional treatments are insufficient to manage hypercapnia (elevated CO2 levels). It can help avoid intubation and mechanical ventilation in some cases. ECCO2R is considered for patients at high risk of ventilator-associated lung injury, barotrauma, or oxygen toxicity when undergoing mechanical ventilation.

These Devices are crucial in managing acute respiratory distress syndrome (ARDS), a severe and often life-threatening condition characterized by profound respiratory failure. In ARDS, the lungs become severely inflamed and filled with fluid, impairing their ability to oxygenate the blood and eliminate carbon dioxide (CO2). ECCO2R devices are used in ARDS cases to address elevated CO2 levels, a condition known as hypercapnia.

By diverting a portion of the patient's blood to the ECCO2R machine, which employs a specialized membrane to remove excess CO2 and reinfuses the blood with oxygen, these devices help reduce the burden on the compromised lungs. This allows for a gentler and less invasive mechanical ventilation strategy, which can prevent ventilator-induced lung injury (VILI) and minimize further harm to the already fragile lung tissue in ARDS patients. ECCO2R serves as a valuable adjunct therapy in ARDS management, supporting the patient's respiratory needs while facilitating the potential for lung recovery.

COPD is a prevalent respiratory condition in North America, primarily affecting older adults. In the United States, COPD was estimated to affect over 16 million adults in 2023, as per the Centres for Disease Control and Prevention. COPD is a primary cause of hospital admissions associated with a substantial economic burden due to healthcare costs and lost productivity. Thus, the growing prevalence of COPD and asthma in the region will drive the growth of the market.

The US market dominated the North America Extracorporeal CO2 Removal Devices Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $35,046.6 Thousands by 2030. The Canada market is experiencing a CAGR of 8.5% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 7.5% during (2023 - 2030).

Based on Application, the market is segmented into Bridge to Lung Transplant, Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS), and Others. Based on End-Use, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers, and Others. Based on Product, the market is segmented into Extracorporeal CO2 Machines, Disposables, and Others. Based on Access, the market is segmented into Arteriovenous & Venovenous. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Getinge AB, Fresenius Medical Care AG & Co. KGaA , Medica S.P.A., Aferetica srl, LivaNova PLC, ESTOR S.P.A., X-COR Therapeutics

Scope of the Study

Market Segments covered in the Report:

By Application

Bridge To Lung Transplant
Chronic Obstructive Pulmonary Disease (COPD)
Acute Respiratory Distress Syndrome (ARDS)
Others

By End-Use

Hospitals
Clinics
Ambulatory Surgical Centers
Others

By Product

Extracorporeal CO2 Machines
Disposables
Others

By Access

Arteriovenous
Venovenous

By Country

US
Canada
Mexico
Rest of North America

Companies Profiled

Medtronic PLC
Getinge AB
Fresenius Medical Care AG & Co. KGaA
Medica S.P.A.
Aferetica srl
LivaNova PLC
ESTOR S.P.A.
X-COR Therapeutics

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Extracorporeal CO2 Removal Devices Market, by Application
- 1.4.2 North America Extracorporeal CO2 Removal Devices Market, by End-Use
- 1.4.3 North America Extracorporeal CO2 Removal Devices Market, by Product
- 1.4.4 North America Extracorporeal CO2 Removal Devices Market, by Access
- 1.4.5 North America Extracorporeal CO2 Removal Devices Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
3.3 Porter's Five Forces Analysis

Chapter 4. North America Extracorporeal CO2 Removal Devices Market, By Application

4.1 North America Bridge To Lung Transplant Market, By Country
4.2 North America Chronic Obstructive Pulmonary Disease (COPD) Market, By Country
4.3 North America Acute Respiratory Distress Syndrome (ARDS) Market, By Country
4.4 North America Others Market, By Country

Chapter 5. North America Extracorporeal CO2 Removal Devices Market, By End-use

5.1 North America Hospitals Market, By Country
5.2 North America Clinics Market, By Country
5.3 North America Ambulatory Surgical Centers Market, By Country
5.4 North America Others Market, By Country

Chapter 6. North America Extracorporeal CO2 Removal Devices Market, By Product

6.1 North America Extracorporeal CO2 Machines Market, By Country
6.2 North America Disposables Market, By Country
6.3 North America Others Market, By Country

Chapter 7. North America Extracorporeal CO2 Removal Devices Market, By Access

7.1 North America Arteriovenous Market, By Country
7.2 North America Venovenous Market, By Country

Chapter 8. North America Extracorporeal CO2 Removal Devices Market, By Country

8.1 US Extracorporeal CO2 Removal Devices Market
- 8.1.1 US Extracorporeal CO2 Removal Devices Market, By Application
- 8.1.2 US Extracorporeal CO2 Removal Devices Market, By End-use
- 8.1.3 US Extracorporeal CO2 Removal Devices Market, By Product
- 8.1.4 US Extracorporeal CO2 Removal Devices Market, By Access
8.2 Canada Extracorporeal CO2 Removal Devices Market
- 8.2.1 Canada Extracorporeal CO2 Removal Devices Market, By Application
- 8.2.2 Canada Extracorporeal CO2 Removal Devices Market, By End-use
- 8.2.3 Canada Extracorporeal CO2 Removal Devices Market, By Product
- 8.2.4 Canada Extracorporeal CO2 Removal Devices Market, By Access
8.3 Mexico Extracorporeal CO2 Removal Devices Market
- 8.3.1 Mexico Extracorporeal CO2 Removal Devices Market, By Application
- 8.3.2 Mexico Extracorporeal CO2 Removal Devices Market, By End-use
- 8.3.3 Mexico Extracorporeal CO2 Removal Devices Market, By Product
- 8.3.4 Mexico Extracorporeal CO2 Removal Devices Market, By Access
8.4 Rest of North America Extracorporeal CO2 Removal Devices Market
- 8.4.1 Rest of North America Extracorporeal CO2 Removal Devices Market, By Application
- 8.4.2 Rest of North America Extracorporeal CO2 Removal Devices Market, By End-use
- 8.4.3 Rest of North America Extracorporeal CO2 Removal Devices Market, By Product
- 8.4.4 Rest of North America Extracorporeal CO2 Removal Devices Market, By Access

Chapter 9. Company Profiles

9.1 Medtronic PLC
- 9.1.1 Company overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expenses
- 9.1.5 SWOT Analysis
9.2 Getinge AB
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 SWOT Analysis
9.3 Fresenius Medical Care AG & Co. KGaA
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expenses
- 9.3.5 Recent strategies and developments:
  - 9.3.5.1 Product Launches and Product Expansions:
- 9.3.6 SWOT Analysis
9.4 Medica S.p.A.
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Regional Analysis
- 9.4.4 SWOT Analysis
9.5 Aferetica srl
- 9.5.1 Company Overview
- 9.5.2 SWOT Analysis
9.6 LivaNova PLC
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Research & Development Expense
- 9.6.5 SWOT Analysis
9.7 ESTOR S.P.A.
- 9.7.1 Company Overview
- 9.7.2 SWOT Analysis
9.8 X-COR Therapeutics
- 9.8.1 Company Overview
- 9.8.2 SWOT Analysis

LIST OF TABLES

TABLE 1 North America Extracorporeal CO2 Removal Devices Market, 2019 - 2022, USD Thousands
TABLE 2 North America Extracorporeal CO2 Removal Devices Market, 2023 - 2030, USD Thousands
TABLE 3 North America Extracorporeal CO2 Removal Devices Market, By Application, 2019 - 2022, USD Thousands
TABLE 4 North America Extracorporeal CO2 Removal Devices Market, By Application, 2023 - 2030, USD Thousands
TABLE 5 North America Bridge To Lung Transplant Market, By Country, 2019 - 2022, USD Thousands
TABLE 6 North America Bridge To Lung Transplant Market, By Country, 2023 - 2030, USD Thousands
TABLE 7 North America Chronic Obstructive Pulmonary Disease (COPD) Market, By Country, 2019 - 2022, USD Thousands
TABLE 8 North America Chronic Obstructive Pulmonary Disease (COPD) Market, By Country, 2023 - 2030, USD Thousands
TABLE 9 North America Acute Respiratory Distress Syndrome (ARDS) Market, By Country, 2019 - 2022, USD Thousands
TABLE 10 North America Acute Respiratory Distress Syndrome (ARDS) Market, By Country, 2023 - 2030, USD Thousands
TABLE 11 North America Others Market, By Country, 2019 - 2022, USD Thousands
TABLE 12 North America Others Market, By Country, 2023 - 2030, USD Thousands
TABLE 13 North America Extracorporeal CO2 Removal Devices Market, By End-use, 2019 - 2022, USD Thousands
TABLE 14 North America Extracorporeal CO2 Removal Devices Market, By End-use, 2023 - 2030, USD Thousands
TABLE 15 North America Hospitals Market, By Country, 2019 - 2022, USD Thousands
TABLE 16 North America Hospitals Market, By Country, 2023 - 2030, USD Thousands
TABLE 17 North America Clinics Market, By Country, 2019 - 2022, USD Thousands
TABLE 18 North America Clinics Market, By Country, 2023 - 2030, USD Thousands
TABLE 19 North America Ambulatory Surgical Centers Market, By Country, 2019 - 2022, USD Thousands
TABLE 20 North America Ambulatory Surgical Centers Market, By Country, 2023 - 2030, USD Thousands
TABLE 21 North America Others Market, By Country, 2019 - 2022, USD Thousands
TABLE 22 North America Others Market, By Country, 2023 - 2030, USD Thousands
TABLE 23 North America Extracorporeal CO2 Removal Devices Market, By Product, 2019 - 2022, USD Thousands
TABLE 24 North America Extracorporeal CO2 Removal Devices Market, By Product, 2023 - 2030, USD Thousands
TABLE 25 North America Extracorporeal CO2 Machines Market, By Country, 2019 - 2022, USD Thousands
TABLE 26 North America Extracorporeal CO2 Machines Market, By Country, 2023 - 2030, USD Thousands
TABLE 27 North America Disposables Market, By Country, 2019 - 2022, USD Thousands
TABLE 28 North America Disposables Market, By Country, 2023 - 2030, USD Thousands
TABLE 29 North America Others Market, By Country, 2019 - 2022, USD Thousands
TABLE 30 North America Others Market, By Country, 2023 - 2030, USD Thousands
TABLE 31 North America Extracorporeal CO2 Removal Devices Market, By Access, 2019 - 2022, USD Thousands
TABLE 32 North America Extracorporeal CO2 Removal Devices Market, By Access, 2023 - 2030, USD Thousands
TABLE 33 North America Arteriovenous Market, By Country, 2019 - 2022, USD Thousands
TABLE 34 North America Arteriovenous Market, By Country, 2023 - 2030, USD Thousands
TABLE 35 North America Venovenous Market, By Country, 2019 - 2022, USD Thousands
TABLE 36 North America Venovenous Market, By Country, 2023 - 2030, USD Thousands
TABLE 37 North America Extracorporeal CO2 Removal Devices Market, By Country, 2019 - 2022, USD Thousands
TABLE 38 North America Extracorporeal CO2 Removal Devices Market, By Country, 2023 - 2030, USD Thousands
TABLE 39 US Extracorporeal CO2 Removal Devices Market, 2019 - 2022, USD Thousands
TABLE 40 US Extracorporeal CO2 Removal Devices Market, 2023 - 2030, USD Thousands
TABLE 41 US Extracorporeal CO2 Removal Devices Market, By Application, 2019 - 2022, USD Thousands
TABLE 42 US Extracorporeal CO2 Removal Devices Market, By Application, 2023 - 2030, USD Thousands
TABLE 43 US Extracorporeal CO2 Removal Devices Market, By End-use, 2019 - 2022, USD Thousands
TABLE 44 US Extracorporeal CO2 Removal Devices Market, By End-use, 2023 - 2030, USD Thousands
TABLE 45 US Extracorporeal CO2 Removal Devices Market, By Product, 2019 - 2022, USD Thousands
TABLE 46 US Extracorporeal CO2 Removal Devices Market, By Product, 2023 - 2030, USD Thousands
TABLE 47 US Extracorporeal CO2 Removal Devices Market, By Access, 2019 - 2022, USD Thousands
TABLE 48 US Extracorporeal CO2 Removal Devices Market, By Access, 2023 - 2030, USD Thousands
TABLE 49 Canada Extracorporeal CO2 Removal Devices Market, 2019 - 2022, USD Thousands
TABLE 50 Canada Extracorporeal CO2 Removal Devices Market, 2023 - 2030, USD Thousands
TABLE 51 Canada Extracorporeal CO2 Removal Devices Market, By Application, 2019 - 2022, USD Thousands
TABLE 52 Canada Extracorporeal CO2 Removal Devices Market, By Application, 2023 - 2030, USD Thousands
TABLE 53 Canada Extracorporeal CO2 Removal Devices Market, By End-use, 2019 - 2022, USD Thousands
TABLE 54 Canada Extracorporeal CO2 Removal Devices Market, By End-use, 2023 - 2030, USD Thousands
TABLE 55 Canada Extracorporeal CO2 Removal Devices Market, By Product, 2019 - 2022, USD Thousands
TABLE 56 Canada Extracorporeal CO2 Removal Devices Market, By Product, 2023 - 2030, USD Thousands
TABLE 57 Canada Extracorporeal CO2 Removal Devices Market, By Access, 2019 - 2022, USD Thousands
TABLE 58 Canada Extracorporeal CO2 Removal Devices Market, By Access, 2023 - 2030, USD Thousands
TABLE 59 Mexico Extracorporeal CO2 Removal Devices Market, 2019 - 2022, USD Thousands
TABLE 60 Mexico Extracorporeal CO2 Removal Devices Market, 2023 - 2030, USD Thousands
TABLE 61 Mexico Extracorporeal CO2 Removal Devices Market, By Application, 2019 - 2022, USD Thousands
TABLE 62 Mexico Extracorporeal CO2 Removal Devices Market, By Application, 2023 - 2030, USD Thousands
TABLE 63 Mexico Extracorporeal CO2 Removal Devices Market, By End-use, 2019 - 2022, USD Thousands
TABLE 64 Mexico Extracorporeal CO2 Removal Devices Market, By End-use, 2023 - 2030, USD Thousands
TABLE 65 Mexico Extracorporeal CO2 Removal Devices Market, By Product, 2019 - 2022, USD Thousands
TABLE 66 Mexico Extracorporeal CO2 Removal Devices Market, By Product, 2023 - 2030, USD Thousands
TABLE 67 Mexico Extracorporeal CO2 Removal Devices Market, By Access, 2019 - 2022, USD Thousands
TABLE 68 Mexico Extracorporeal CO2 Removal Devices Market, By Access, 2023 - 2030, USD Thousands
TABLE 69 Rest of North America Extracorporeal CO2 Removal Devices Market, 2019 - 2022, USD Thousands
TABLE 70 Rest of North America Extracorporeal CO2 Removal Devices Market, 2023 - 2030, USD Thousands
TABLE 71 Rest of North America Extracorporeal CO2 Removal Devices Market, By Application, 2019 - 2022, USD Thousands
TABLE 72 Rest of North America Extracorporeal CO2 Removal Devices Market, By Application, 2023 - 2030, USD Thousands
TABLE 73 Rest of North America Extracorporeal CO2 Removal Devices Market, By End-use, 2019 - 2022, USD Thousands
TABLE 74 Rest of North America Extracorporeal CO2 Removal Devices Market, By End-use, 2023 - 2030, USD Thousands
TABLE 75 Rest of North America Extracorporeal CO2 Removal Devices Market, By Product, 2019 - 2022, USD Thousands
TABLE 76 Rest of North America Extracorporeal CO2 Removal Devices Market, By Product, 2023 - 2030, USD Thousands
TABLE 77 Rest of North America Extracorporeal CO2 Removal Devices Market, By Access, 2019 - 2022, USD Thousands
TABLE 78 Rest of North America Extracorporeal CO2 Removal Devices Market, By Access, 2023 - 2030, USD Thousands
TABLE 79 Key Information - Medtronic PLC
TABLE 80 Key Information - Getinge AB
TABLE 81 Key Information - Fresenius Medical Care AG & Co. KGaA
TABLE 82 Key Information - Medica S.p.A.
TABLE 83 Key Information - Aferetica srl
TABLE 84 Key Information - LivaNova PLC
TABLE 85 Key Information - ESTOR S.P.A.
TABLE 86 Key Information - X-COR Therapeutics

North America Extracorporeal CO2 Removal Devices Market Size, Share & Industry Trends Analysis Report By Application, By End-Use, By Product, By Access, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents